Reactivation of Epstein-Barr Virus in SFTSV Infected Patients
Overview
Affiliations
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever caused by a tick-borne bunyavirus SFTSV with case fatality up to 30%. The reactivation of Epstein-Barr virus (EBV) has been proven to occur in individuals with various immune suppression conditions.
Methods: Here, we diagnosed 22 SFTSV infected patients with PCR in a hospital in Shandong Province, China in 2020. To understand the consequences of SFTSV infection leading to EBV reactivation, we examined EBV reactivation in SFTSV-infected patients with PCR and RT-PCR.
Results: We found that EBV was reactivated in 18.2% (4/22) of SFTS patients, suggesting that EBV reactivation is common in SFTS patients. Compared with SFTS patients without EBV reactivation, SFTS patients with EBV-reactivation had a significantly lower median level of serum albumin (32.45 g/L vs. 26.95 g/L, = 0.03) and a significantly higher median number of urine red blood cells (0 cells/μL vs. 9 cells/μL, = 0.04).
Conclusion: SFTS infection can reactivate EBV in patients, which may make the clinical condition of patients worsen.
Virome analysis provides new insights into the pathogenesis mechanism and treatment of SLE disease.
Wu Y, Zhang Z, Wang X, Liu X, Qiu Y, Ge X Front Cell Infect Microbiol. 2024; 14:1484529.
PMID: 39512588 PMC: 11540821. DOI: 10.3389/fcimb.2024.1484529.
Ten computational challenges in human virome studies.
Wu Y, Peng Y Virol Sin. 2024; 39(6):845-850.
PMID: 38697263 PMC: 11738758. DOI: 10.1016/j.virs.2024.04.008.
The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies.
Chinna P, Bratl K, Lambarey H, Blumenthal M, Schafer G Int J Mol Sci. 2023; 24(17).
PMID: 37685871 PMC: 10487760. DOI: 10.3390/ijms241713066.